Piperazine derivatives

Details Piperazine derivatives Piperazine derivatives

2011-07-26

2011-07-26

Ward, Paul V. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S358000

Reexamination Certificate

active

07985751

ABSTRACT:
Compounds of general formula (I)in which R1and R0have any of the meanings given in the specification have affinity for sigma receptors and are useful in the treatment of disorders of the central nervous system.

REFERENCES:
patent: 5389630 (1995-02-01), Sato et al.
patent: 5736546 (1998-04-01), Kawashima et al.
patent: 2003/0171347 (2003-09-01), Matsumoto
patent: WO 91/09594 (1991-07-01), None
patent: WO 2004/110387 (2004-12-01), None
Kazunori Kawamura et al., “Improved syntheis . . . ” Annals of Nuclear Medicine, vol. 18, No. 2, 165-1168, 2004.
Matsumoto et al., “Structure-activity comparison . . . ”, Pharmacology Biochemistry & Behavior 77 (2004) 775-581.
Fujimura et al., “Synthesis, Structure . . . ” Bio & Med Chem, vol. 5, No. 8 pp. 1675-1683, 1997.
Elsinga et al., “Evaluation of Fluorinated sigma receptor . . . ”, Synapse 52:29-37 2004.

Affiliated with

Also associated with

Rating

Piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2718785